Health Affairs September 20, 2022
Eric Roberts, Alan Weil

Alan Weil interviews Eric Roberts from the University of Pittsburgh School of Public Health to discuss his and colleagues recent...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Govt Agencies, Insurance, Medicare, Medicare Advantage, Patient / Consumer, Provider, Trends
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article